HLA-DQB1 codon 57 is critical for peptide binding and recognition

Area of Science:

• Immunology
• Molecular Biology
• Genetics

Background:

• Specific Human Leukocyte Antigen (HLA)-DQ alleles are linked to autoimmunity due to sequence polymorphisms affecting peptide recognition.
• Polymorphism at residue 57 of the DQB1 polypeptide is critical for the structural integrity of the peptide-binding cleft in HLA-DQ molecules.

Purpose of the Study:

• To investigate the role of amino acid polymorphism at residue 57 in HLA-DQ molecules as a determinant for peptide binding and T cell stimulation.
• To elucidate the structural and functional significance of residue 57 variations in HLA-DQ-mediated immune responses.

Main Methods:

• Directly tested amino acid substitutions at residue 57 of HLA-DQ molecules.
• Assessed peptide binding affinities to different HLA-DQ variants.
• Evaluated antigen-specific T cell stimulation using modified peptides and HLA-DQ molecules.

Main Results:

• A single Ala-->Asp substitution at residue 57 in HLA-DQ3.2 altered the binding of an HSV-2 VP-16-derived peptide.
• Complementary peptide modification enabled binding to Asp-57-positive HLA-DQ3.1 and DQ3.3 molecules, while abolishing binding to DQ3.2.
• T cell recognition studies confirmed that residue 57 polymorphism dictates T cell reactivity to specific peptide-MHC complexes.

Conclusions:

• The amino acid at residue 57 of HLA-DQ molecules is a key determinant of peptide binding specificity.
• Variations at residue 57 significantly impact T cell recognition, influencing HLA-DQ-restricted immune responses.
• Understanding these polymorphisms is vital for comprehending the genetic basis of autoimmunity and designing targeted immunotherapies.